BridgeMD
New treatment option for Breast Cancer Female
Official title Dermatitis During Adjuvant Irradiation for BREAst Cancer:
ClinicalTrials.gov ID: NCT06483477
What this study is testing
- What it's testing
- In the randomized DAI-BREAC trial, a reminder app will be prospectively tested that reminds breast cancer patients four times each day to perform the required skin care. This will likely contribute to the reduction of grade ≥2 radiation dermatitis in these patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Histologically proven invasive breast cancer
- Indication for adjuvant hypo-fractionated radiotherapy
- Possession of and ability to use a smartphone
- Female gender
- Age ≥18 years
You likely can't join if
- Pregnancy, Lactation
- Expected non-compliance
See the full eligibility criteria
- Histologically proven invasive breast cancer
- Indication for adjuvant hypo-fractionated radiotherapy
- Possession of and ability to use a smartphone
- Female gender
- Age ≥18 years
- Written informed consent
- Capacity of the patient to contract
- Pregnancy, Lactation
- Expected non-compliance
The study team makes the final eligibility decision.
Where it's taking place
- Vejle, Southern Denmark, Denmark
- Hanover, Lower Saxony, Germany
- Schwerin, Mecklenburg-Vorpommern, Germany
- Flensburg, Schleswig-Holstein, Germany
- Lübeck, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vejle, Southern Denmark, Denmark; Hanover, Lower Saxony, Germany; Schwerin, Mecklenburg-Vorpommern, Germany; Flensburg, Schleswig-Holstein, Germany; Lübeck, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.